Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J R, Dorin"'
Autor:
S. Jansen, Ivo Steinmetz, Wolfgang Bernhard, J. R. Dorin, Thomas Tschernig, Hans-Jürgen Hedrich, M. Larbig, B. Bellmann, David J. Porteous, B. Tuemmler, H. von der Hardt, M. Dorsch
Publikováno v:
Pathobiology. 70:89-97
Mouse models for cystic fibrosis (CF) mimic intestinal manifestations of the human disease, but the lung disease phenotypes are lacking in most strains. In this work, the issue was addressed whether aging of the respiratory tract leads to lung pathop
Autor:
Ray Farley, Stephen Delaney, Brandon J. Wainwright, Stephen N. Smith, David A. Hume, J. R. Dorin, Dominic P. Lunn, Scott Thomson, David J. Porteous, Eric W.F.W. Alton, David Lamb, Paul K. Lovelock
Publikováno v:
The EMBO Journal. 15:955-963
We have generated a mouse carrying the human G551D mutation in the cystic fibrosis transmembrane conductance regulator gene (CFTR) by a one-step gene targeting procedure. These mutant mice show cystic fibrosis pathology but have a reduced risk of fat
Autor:
J. R. Dorin, David J. Porteous
Publikováno v:
Thorax. 46:46-55
Autor:
Isla J. Campbell, Paul Dickinson, David J. Porteous, Fiona Kilanowski, Sheila Webb, J. R. Dorin, Hugo R. de Jonge, Martin S. Taylor, Eric W.F.W. Alton, Rob Willemsen, Stephen N. Smith, Ray Farley
Publikováno v:
Dickinson, P, Smith, S N, Webb, S, Kilanowski, F M, Campbell, I J, Taylor, M S, Porteous, D J, Willemsen, R, de Jonge, H R, Farley, R, Alton, E W F W & Dorin, J R 2002, ' The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics ', Human Molecular Genetics, vol. 11, no. 3, pp. 243-51 . https://doi.org/10.1093/hmg/11.3.243
Human Molecular Genetics, 11, 243-251. Oxford University Press
Human Molecular Genetics, 11, 243-251. Oxford University Press
The majority of cystic fibrosis patients produce a mutant form of CFTR (DeltaF508) which has been shown to be mislocalized in both humans and mice. G480C, another clinically 'severe' mutation, has also been demonstrated to be defective in its intrace
Autor:
P, Dickinson, W L, Kimber, F M, Kilanowski, S, Webb, B J, Stevenson, D J, Porteous, J R, Dorin
Publikováno v:
Transgenic research. 9(1)
The creation of precise clinical mutations by targeting is important in elucidating disease pathogenesis using mouse models. 'Hit and run' gene targeting is an elegant method to achieve this goal. This uses first a positive selection to introduce the
Autor:
David J. Porteous, F. Dupuit, E. Puchelle, J. R. Dorin, J.M. Zahm, Dominique Gaillard, Jocelyne Hinnrasky
Publikováno v:
The American journal of physiology. 272(3 Pt 1)
In cystic fibrosis (CF), whether cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction leads to decreased mucociliary clearance and mucus hypersecretion, before bacterial infection, remains an open question. To answer this question,
Autor:
G, McLachlan, L P, Ho, H, Davidson-Smith, J, Samways, H, Davidson, B J, Stevenson, A D, Carothers, E W, Alton, P G, Middleton, S N, Smith, G, Kallmeyer, U, Michaelis, S, Seeber, K, Naujoks, A P, Greening, J A, Innes, J R, Dorin, D J, Porteous
Publikováno v:
Gene therapy. 3(12)
The first phase I study of cystic fibrosis gene therapy using cationic liposomes to deliver the cystic fibrosis conductance regulator gene to the nose reported partial and transient correction of the nasal transepithelial ion transport defect, While
Autor:
J R, Dorin, R, Farley, S, Webb, S N, Smith, E, Farini, S J, Delaney, B J, Wainwright, E W, Alton, D J, Porteous
Publikováno v:
Gene therapy. 3(9)
Quantifying the level of transgene expression necessary for phenotypic effect is an important consideration in designing somatic gene therapy protocols. A nonlinear relationship between phenotype and gene activity is predicted by control analysis for
Autor:
J. R. Dorin, D. M. Steel, Ewfw Alton, Stephen N. Smith, Peter G. Middleton, Natasha J. Caplen, Felix M. Munkonge, David J. Porteous, Duncan M. Geddes
Publikováno v:
The American journal of physiology. 268(2 Pt 1)
Two important issues that can be addressed by animal models are disease pathogenesis and the testing of new treatments, including gene therapy. How closely these models mimic the relevant disorder in humans will determine their usefulness. This study